Skip to content
Open access

Outcomes of Upfront Surgery Versus Neoadjuvant Therapy-Preceded Surgery in Patients of Luminal A Breast Cancer with Axillary Nodal Involvement, A Prospective Comparative Study

Oct 2026 · International Journal of Drug Delivery Technology · Vol 16 · 0 citations

TL;DR

Neoadjuvant chemotherapy has a beneficial effect on nodal status of luminal A EBC patients; constituting for skipping the formal axillary lymph node dissection (ALND) and it does not reduce the breast and axillary post-operative complications to significant values.

Abstract

Background: Luminal A is the most common molecular subtype of breast cancer (BC), in which the neoadjuvant chemotherapy (NAC) is less effective compared to other subtypes. we studied the surgical outcomes of upfront surgery versus the NAC preceded surgery in patients of luminal A early breast cancer (EBC) with axillary nodal involvement. Patients and Methods: It is a prospective comparative randomized study conducted in EL Demerdash Hospital that extended for about two years starting from January 2023. forty female patients with nodal positive early luminal A BC were randomly divided into two equal groups, one of which received NAC before surgery and the other proceeded directly to surgery with a follow up period of about 6 months. Data was analyzed to evaluate short-term outcomes following both strategies. Results: Post NAC clinical nodal conversion was 30% ( p = 0.007), of which four patients (20%) achieved a nodal pathological complete response (NpCR). Reduction in tumor size after NAC was non-significant ( p = 0.081) together with the rate of conversion to breast conservative surgery (BCS), p = 0.308. Post-operative complications were comparable between both groups, with overall morbidity of (35 %) in upfront surgery group compared to (25%) in the NAC one, p = 0.490. Conclusion: Neoadjuvant chemotherapy has a beneficial effect on nodal status of luminal A EBC patients; constituting for skipping the formal axillary lymph node dissection (ALND). Its effect on the breast mass is limited, and it doesn’t reduce the breast and axillary post-operative complications to significant values.

Read PDF

Similar papers

Open access Oct 2026

Effect of neoadjuvant chemotherapy on surgical outcomes in Danish breast cancer patients between 2018-2023.

INTRODUCTION Neoadjuvant chemotherapy (NACT) has been used nationwide in Denmark to downsize tumour and for downstaging of metastases in the axilla. Although several studies have assessed the impact of NACT on surgical complications after immediate breast reconstruction (IBR), the available evidence remains inconsisten...

Sinem Saritaş, A. S. Brems-Eskildsen, Louise Bønnelykke-Behrndtz et al. · 0 citations
Open access 2026

Survival outcomes, treatment response, and prognostic factors of different treatment modalities in patients with epithelial ovarian cancer: a retrospective cohort study.

PDS and NACT+IDS offer comparable survival outcomes in patients with advanced EOC, whereas NACT+IDS is associated with improved perioperative safety and higher tumor response rates without increasing severe chemotherapy-related toxicity.

Yong-Hui Zou, Yan-Qiu Wang, Ming-Jun Fan et al. · 0 citations
Open access Oct 2026

Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety

Comparing the survival outcomes and recurrence patterns of radical surgery and definitive radiotherapy following NICT in patients with LA-ESCC concluded that Definitive RT may be an organ-preserving option in selected patients, especially those with upper esophageal cancer or a favorable response to NICT.

Q. An, Ya-Ge Jia, Meng-Lu Liu et al. · 0 citations
Open access Oct 2026

Impact of Neoadjuvant Chemotherapy on Pathological Outcomes and Survival in Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Analysis

Neoadjuvant chemotherapy (NAC) is recommended for patients with muscle-invasive bladder cancer (MIBC); however, its impact on survival outcomes remains controversial in real-world clinical settings. This retrospective observational study evaluated the effect of NAC on pathological outcomes and overall survival among pa...

I. Topcu, Bulut Dural, Ömer Faruk Yıldırım et al. · 0 citations
Open access Sep 2026

Three-year survival in patients with cT4N0 breast cancer after neoadjuvant systemic therapy according to the extent of axillary surgery

Purpose. To compare 3-year survival outcomes in patients with cT4N0M0 breast cancer who achieved ycN0 status after neoadjuvant systemic therapy (NAST), according to the extent of axillary surgery. Materials and Methods. This single-center, prospective, nonrandomized cohort study included a historical control g...

M. Kurbanova, V. Amosova, M. Frolova et al. · 0 citations
Open access Oct 2026

Comparative Clinical Outcomes and Recurrence Patterns Following Mastectomy versus Breast Conserving Surgery in Female Breast Cancer Patients: A Multicenter Retrospective Cohort Study in Western Libya

Breast cancer is the most common cancer diagnosed in women worldwide. In high-income countries, breast-conserving surgery combined with radiotherapy gives survival similar to mastectomy in early-stage disease. Whether this holds in low-resource settings such as Libya, where radiotherapy access and follow-up are less co...

Suzan Abusahmen, Fadia Oshkondale, Sumia Draa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.